BASF Partners with Academia on Bioprocess Scale-Up PhD Program
BASF and three universities have established a new PhD training program. It will equip students with the knowledge and skills to improve scale-up techniques for producing chemicals, food ingredients, and materials more sustainably, or...
Salutogenic microbes offer new pathways to better health
Viruses and bacteria get a bad rap around the world but now Flinders University experts are identifying the positive 'upside' of powerful benefits that microbes have on human health.
Flinders microbial ecologist Dr. Jake Robinson...
Traumatic brain injury disrupts brain drainage and accelerates Alzheimer’s risk
University of Virginia School of Medicine researchers have uncovered how and why traumatic brain injury (TBI) increases the risk for Alzheimer's disease, and their work suggests a potential way to prevent that increased risk.John...
Neuron structure variations impact sensory information processing in mice
Closely related subtypes of dopamine-releasing neurons may play entirely separate roles in processing sensory information, depending on their physical structure. New research from the Institute of Psychiatry, Psychology & Neuroscience (IoPPN) at King's College...
Scientists engineer AbLecs to overcome cancer’s immune evasion tactics
Researchers at MIT and Stanford University have developed a new way to stimulate the immune system to attack tumor cells, using a strategy that could make cancer immunotherapy work for many more patients. The...
Keeping Neutrophils in Night Mode Could Reduce Post-Heart Attack Inflammation
Heart attacks that occur at night are less severe than those that strike during the day. A new study headed by researchers at the Centro Nacional de Investigaciones Cardiovasculares (CNIC) and at Yale University...
StockWatch: Positive Obesity Pill Data Has Structure Investors Seeing Double
As Eli Lilly (NYSE: LLY) and Novo Nordisk (Nasdaq Copenhagen: NOVO-B) scramble to bring an oral glucagon-like peptide 1 (GLP-1) receptor agonist to market for obesity, a much smaller potential rival spotlighted positive mid-stage...
SN101 iPSC-derived therapy relieves chronic pain and preserves joints
SereNeuro Therapeutics, a preclinical biotechnology company developing non-opioid pain therapies, unveiled new data today on a novel approach to chronic pain management and joint tissue preservation. The data highlights SN101, a first-in-class induced pluripotent...
Exclusive licensing agreement accelerates PHD inhibitor development for anemia in CKD patients
Insilico Medicine ("Insilico"), a clinical-stage generative artificial intelligence (AI)-driven drug discovery company, and TaiGen Biotechnology, a listed discovery-based and market-focused pharmaceutical company, as well as TaiGen Biopharmaceuticals, its wholly-owned Beijing subsidiary (both referred to...
Concordia University Expands Sustainable Biomanufacturing Capacity with $5M Investment
Concordia expanded its sustainable biomanufacturing capacities with upgrades to its Genome Foundry and bioprocessing facilities as the result of a $5 million Canada Foundation for Innovation (CFI) fund investment, which is funded 40% by the CFI, with...
